Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.202
-0.126 (-9.49%)
Feb 11, 2026, 11:11 AM CET
Pila Pharma AB Revenue
In the year 2025, Pila Pharma AB had annual revenue of 1.13M SEK with 42.68% growth. Pila Pharma AB had revenue of 276.00K in the half year ending December 31, 2025, a decrease of -24.59%.
Revenue
1.13M
Revenue Growth
+42.68%
P/S Ratio
58.35
Revenue / Employee
957.89K
Employees
1
Market Cap
55.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.13M | 337.11K | 42.68% |
| Dec 31, 2024 | 789.89K | -673.13K | -46.01% |
| Dec 31, 2023 | 1.46M | -417.72K | -22.21% |
| Dec 31, 2022 | 1.88M | 1.16M | 161.49% |
| Dec 31, 2021 | 719.23K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alligator Bioscience AB | 46.22M |
| Alzinova AB | 26.12M |
| Nanologica AB | 22.65M |
| Scandinavian ChemoTech AB | 11.68M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| AcouSort AB | 10.80M |
| Spago Nanomedical AB | 5.84M |
| OncoZenge AB | 2.78M |